Literature DB >> 19943187

Natural hidden autoantibodies to tissue transglutaminase cross-react with fibrinogen.

Ingrid M Zöller-Utz1, Birgit Esslinger, Anja Schulze-Krebs, Walburga Dieterich.   

Abstract

INTRODUCTION: Patients with celiac disease display autoantibodies against tissue transglutaminase (TG2), and the high sensitivity and specificity of these autoantibodies render them a reliable tool for diagnosis. However, we found that denatured sera from healthy persons also showed reactivity against TG2.
METHODS: To further examine the specificity of this phenomenon, sera of healthy individuals and celiac patients were denatured by heat or pH shift. RESULTS AND DISCUSSION: Denatured sera of all individuals showed autoantibodies against TG2 in ELISA that could be specifically inhibited by TG2, but the biological role of these autoantibodies remains unknown. The alpha fibrinogen precursor could be isolated as serum protein that reacts with TG2 antibodies and treated sera reacted with fibrinogen in Western blotting. Cross-reactivity of TG2 antibodies with fibrinogen and vice versa was observed.
CONCLUSION: We hypothesise that denaturation of sera reveals hidden autoantibodies against TG2, which might be normally masked by fibrinogen.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19943187     DOI: 10.1007/s10875-009-9347-z

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  39 in total

Review 1.  Molecular basis of celiac disease.

Authors:  L M Sollid
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

Review 2.  The prevalence of celiac disease in average-risk and at-risk Western European populations: a systematic review.

Authors:  Catherine Dubé; Alaa Rostom; Richmond Sy; Ann Cranney; Navaaz Saloojee; Chantelle Garritty; Margaret Sampson; Li Zhang; Fatemeh Yazdi; Vasil Mamaladze; Irene Pan; Joanne Macneil; David Mack; Dilip Patel; David Moher
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

3.  Identification of tissue transglutaminase as the autoantigen of celiac disease.

Authors:  W Dieterich; T Ehnis; M Bauer; P Donner; U Volta; E O Riecken; D Schuppan
Journal:  Nat Med       Date:  1997-07       Impact factor: 53.440

4.  Effect of using heat-inactivated serum with the Abbott human T-cell lymphotropic virus type III antibody test.

Authors:  D L Jungkind; S A DiRenzo; S J Young
Journal:  J Clin Microbiol       Date:  1986-02       Impact factor: 5.948

5.  Anti-endothelial cell antibodies in systemic vasculitis and systemic lupus erythematosus (SLE): effects of heat inactivation on binding and specificity.

Authors:  D P D'Cruz; G Keser; H Direskeneli; M A Khamashta; G R Hughes
Journal:  Clin Exp Immunol       Date:  1999-03       Impact factor: 4.330

6.  Heat treatment of normal human sera reveals antibodies to bactericidal permeability-inducing protein (BPI).

Authors:  A A Brownlee; C M Lockwood
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

7.  Detection of Celiac disease in primary care: a multicenter case-finding study in North America.

Authors:  Carlo Catassi; Deborah Kryszak; Otto Louis-Jacques; Donald R Duerksen; Ivor Hill; Sheila E Crowe; Andrew R Brown; Nicholas J Procaccini; Brigid A Wonderly; Paul Hartley; James Moreci; Nathan Bennett; Karoly Horvath; Margaret Burk; Alessio Fasano
Journal:  Am J Gastroenterol       Date:  2007-03-13       Impact factor: 10.864

8.  Identification of target antigens of self-reactive IgG in intravenous immunoglobulin preparations.

Authors:  Guillaume Bussone; Hanadi Dib; Jordan D Dimitrov; Luc Camoin; Cédric Broussard; Nicolas Tamas; Loïc Guillevin; Srini V Kaveri; Luc Mouthon
Journal:  Proteomics       Date:  2009-04       Impact factor: 3.984

9.  Autoantibodies to tissue transglutaminase as predictors of celiac disease.

Authors:  W Dieterich; E Laag; H Schöpper; U Volta; A Ferguson; H Gillett; E O Riecken; D Schuppan
Journal:  Gastroenterology       Date:  1998-12       Impact factor: 22.682

10.  Inhibitor(s) of natural anti-cardiolipin autoantibodies.

Authors:  Z Kra-Oz; M Lorber; Y Shoenfeld; Y Scharff
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.